XRAY (Dentsply Sirona) YoY EBITDA Growth: 533.50% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XRAY Dentsply Sirona Inc XRAY
57 GF Score
Price $11.44
GF Value $17.33
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Dentsply Sirona YoY EBITDA Growth?

Dentsply Sirona XRAY +1.15% 57 YoY EBITDA Growth is 533.50% as of Jun. 2026. GuruFocus rates XRAY with a GF Score™ of 57/100 and a GF Value™ of $17.33 (Possible Value Trap). The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Dentsply Sirona's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 533.50%.

Dentsply Sirona's EBITDA per Share for the three months ended in Jun. 2026 was $0.89.

Dentsply Sirona YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Dentsply Sirona's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dentsply Sirona YoY EBITDA Growth Chart

Dentsply Sirona Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 187.24 -171.06 138.25 -316.94 90.94

Dentsply Sirona Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -130.93 68.80 92.41 -57.10 533.50
XRAY
57GF Score
Dentsply Sirona Inc XRAY
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dentsply Sirona YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Dentsply Sirona's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.231--2.549)/ | -2.549 |
=90.94 %

Dentsply Sirona's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.893--0.206)/ | -0.206 |
=533.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 533.50% mean?
Dentsply Sirona (XRAY) has a YoY EBITDA Growth of 533.50% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Dentsply Sirona and its competitors.
Is Dentsply Sirona's YoY EBITDA Growth too high?
Dentsply Sirona's current YoY EBITDA Growth is 533.50%. Overall, Dentsply Sirona has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's YoY EBITDA Growth compare to ATRC and LMAT?
Dentsply Sirona's YoY EBITDA Growth of 533.50% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Dentsply Sirona and its competitors. Dentsply Sirona's current YoY EBITDA Growth is 533.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $17.33, compared to a current price of $11.44 — trading 34% below its estimated fair value. The current YoY EBITDA Growth is 533.50%. Dentsply Sirona's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current YoY EBITDA Growth is 533.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dentsply Sirona (XRAY) Overvalued in 2026?

Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued. The current stock price of $11.44 is trading 34% below its estimated GF Value™ of $17.33. GuruFocus considers Dentsply Sirona to be Possible Value Trap.

Key valuation signals for XRAY:

  • YoY EBITDA Growth: 533.50%
  • GF Value™: $17.33 vs. price of $11.44 (34% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dentsply Sirona Business Description

Address 13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
57GF Score

Get the complete analysis for XRAY

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.44
Price
$17.33
GF Value